|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Articles in PresS, published online ahead of print October 31, 2001
Am J Physiol Cell Physiol, 10.1152/ajpcell.00101.2001
Submitted on February 27, 2001
Accepted on October 24, 2001
1 School of Veterinary Medicine, Laboratory of Developmental Biotechnology, Sagamihara, Kanagawa, Japan
2 School of Veterinary Medicine, Laboratory of Food Science, Sagamihara, Kanagawa, Japan
* To whom correspondence should be addressed. E-mail: takizawa{at}azabu-u.ac.jp.
Nitric oxide (NO) production in the rat placenta was monitored and quantified by electron paramagnetic resonance (EPR) spectroscopy using hemoglobin and an iron complex with N-(dithiocarboxy) sarcosine (DTCS) as NO trapping reagents. The expression of nitric oxide synthase (NOS) isoforms was also examined by quantitative reverse transcriptase-mediated polymerase chain reaction (RT-PCR) analysis. The EPR spectrum of the placenta with hemoglobin trapping showed a three-line hyperfine structure (g=2.008 and a 1.66 mT). The EPR signal was diminished after the placenta was homogenized or NOS inhibitor NG-nitro-L-arginine methyl ester was administered to pregnant rats. Therefore, the specific signal was definitely identified as being derived from endogenous NO spin-trapped by hemoglobin, and the EPR spectrum showed that the NO adduct existed as a pentacoordinate
-NO heme species. The EPR spectrum of the placenta with Fe-DTCS trapping showed a triplet signal (g=2.038) derived from an NO-Fe-DTCS complex. The height of the triplet signal did not vary significantly with gestational stage in the placenta during the last few days of gestation. At the gestational stages examined, the level of NOS II mRNA expression was significantly higher than that of NOS III mRNA expression at a given stage in the placenta. NOS II expression in term (day 21.5) placenta was significantly increased compared to that in preterm (day 19.5) placenta (p<0.01, n= 4 or 5). These results suggest that NOS II is the predominant producer of NO in the placenta and that NOS II-generated NO plays significant roles in the maintenance of placental functions immediately before birth.
This article has been cited by other articles:
![]() |
M. Chauhan, U. Yallampalli, L. Reed, and C. Yallampalli Adrenomedullin 2 Antagonist Infusion to Rats During Midgestation Causes Fetoplacental Growth Restriction Through Apoptosis Biol Reprod, December 1, 2006; 75(6): 940 - 947. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Schaffer, J. Vogel, C. Breymann, M. Gassmann, and H. H. Marti Preserved placental oxygenation and development during severe systemic hypoxia Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2006; 290(3): R844 - R851. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |